Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Algorae Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Oneview extends software deal, LCT to start using AI technology
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
News
Reporting Season Round Up: Who shined on the ASX’s Judgement Day?
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
News
ASX Capital Raise Roundup: Low expectations + strong earnings =
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
10 at 10: These ASX stocks have floated up high this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
News
Weekly small cap wrap: Who received an award this week?
Health & Biotech
Check-up: Orthocell races ahead to lead the health and biotech pack
News
Rise and Shine: What you need to know before the ASX opens
News